Santis partners with Angiodroid to bring CO₂ injection innovation to Bulgaria

We are excited to announce a new partnership between Santis and Angiodroid, the leading Italian manufacturer of automated carbon dioxide (CO₂) injection systems for angiography.

Under this agreement, Santis becomes the official distributor of Angiodroid’s solutions for the Bulgarian market, expanding our cardiology and interventional imaging portfolio.

Angiodroid’s technology offers a safe, contrast-free alternative to traditional iodinated agents, especially beneficial for patients with renal impairment or contrast media allergies. With a fully automated system, Angiodroid ensures precision, safety, and efficiency during angiographic procedures.

This partnership reflects our ongoing mission to bring cutting-edge and patient-friendly technologies to healthcare providers in Bulgaria.

By adding Angiodroid to our portfolio, Santis reinforces its position as a value-driven distributor committed to innovation and improved patient outcomes.

Santis – Value in Every Connection.